Valid

YY/T 0573.4-2020Sterile hypodermic syringes for single use - Part 4: Syringes with re-use prevention feature (English PDF)

一次性使用无菌注射器 第4部分:防止重复使用注射器

Preview PDF

This is a limited preview

Buy now to download the full PDF (37 pages)

Need quotation for your management?

Get a formal quotation for YY/T 0573.4-2020 in 30 minutes.

Issued by

NMPA

Level / Type

Industry · Recommended

Issue date

February 26, 2020

Implementation date

March 1, 2021

Scope

YY/T 0573.4-2020 is the English-translated version of 一次性使用无菌注射器 第4部分:防止重复使用注射器.

YY/T 0573.4-2020 is the Chinese standard "Sterile hypodermic syringes for single use - Part 4: Syringes with re-use prevention fracture".

Its scope clause reads: This part of YY/T 0573 specifies the terms and definitions, naming and classification, physical requirements, chemical requirements, biological requirements, packaging, markings, etc. of sterile hypodermic syringes for single use (hereinafter referred to as syringes) with re-use prevention features.

This part applies to sterile hypodermic syringes for single use, which are made of plastic materials, with or without needles, used for aspirating liquids OR for injection immediately after aspirating liquids, designed to prevent re-use.

It is suitable for the re-use prevention performance of syringe, which can prevent accidental needle stick injury. This part does not involve the performance of preventing accidental needle stick injury of this type of syringe.

This part does not apply to glass syringes, self-destructive fixed-dose vaccine syringes, syringes with prefilled liquid medicine. This part does not involve the.

Its clauses include terms and definitions; naming and classification; physical requirements; chemical requirements; biological requirements; packaging; signs. It was issued by the National Medical Products Administration on FEBRUARY 26, 2020 and took effect on MARCH 01, 2021.

Found what you need?

Document preview — YY/T 0573.4-2020

National Standard of the People's Republic of China

Replacing
YY 0573.4-2010

Issued by: National Medical Products Administration of the People's Republic of China

Contents

  • Foreword3
  • 1 Scope7
  • 2 Normative references7
  • 3 Terms and definitions8
  • 4 Naming and classification8
  • 5 Physical requirements10
  • 6 Chemical requirements16
  • 7 Biological requirements16
  • 8 Packaging17
  • 9 Signs18
  • Appendix A (Normative) Test method for capacity tolerance and residual capacity22
  • Appendix B (Normative) Test method for leakage at the connection between the fixed needle tube and the needle seat, at the piston or sealing ring, when the syringe is under positive pressure25
  • Appendix C (Normative) Test method for leakage at piston or sealing ring AND separation of piston and core rod, when syringe is pumped under negative pressure27
  • Appendix D (Normative) Test method for fit between jacket and piston assembly30
  • Appendix E (Normative) Test methods of re-use prevention features31
  • Appendix F (Normative) Preparation of extraction solution and test method33
  • Appendix G (Informative) Guidelines for design and materials35
  • References37

Foreword

YY/T 0573 "Sterile hypodermic syringes for single use" consists of the following parts:

- Part 2: Syringes for use with power-driven syringe pumps;

- Part 3: Auto-disable syringes for fixed dose immunization;

- Part 4: Syringes with re-use prevention feature.

This part is part 4 of YY/T 0573.

GB 15810 "Sterile syringes for single use" adopts, through modification, the ISO 7886-1 "Sterile hypodermic syringes for single use - Part 1: Syringes for manual use". Therefore, the standard series of YY/T 0573 "Sterile hypodermic syringes for single use" does not have part 1.

This part was drafted in accordance with the rules given in GB/T 1.1-2009.

This part replaces YY 0573.4-2010 "Sterile hypodermic syringes for single use - Part 4: Syringes with re-use prevention feature".

Compared with YY 0573.4-2010, the main technical changes in this part are as follows:

- INTRODUCE the content of 15.4 "Performance after shipment" into 8.3 "Large package" (see 8.3);

- ADD the requirements for easy oxides and ethylene oxide residues, in the chemical requirements (see 6.3, 6.4);

- ADD the requirements for sterility and bacterial endotoxins, in the biological requirements (see 7.2, 7.3);

- MODIFY the requirements of "initial packaging or self-sealing packaging" (see 8.1; Chapter 16 of the 2010 edition);

- ADD the Appendix A "Test methods for capacity tolerance and residual capacity" (see Appendix A);

- ADD the Appendix B "Test method for leakage at the connection of the fixed needle tube and the needle seat, at the piston or seal ring, when the syringe is under positive pressure" (see Appendix B);

- ADD the Appendix C "Test method for leakage, at piston or sealing ring AND separation of piston and core rod, when syringe is pumped under negative pressure" (see Appendix C);

- ADD the Appendix D "Test method for fit between jacket and piston assembly" (see Appendix D);

- ADD F.2 "Test method for residual ethylene oxide" (see Appendix F);

- ADD the Appendix G "Guidelines for design and materials" (see Appendix G);

- DELETE the Appendix C "Environmental aspects" of the original standard (see Appendix C of the 2010 edition).

This part uses the redrafting method to modify and adopt ISO 7886-4:2006 "Sterile hypodermic syringes for single use - Part 4: Syringes with re-use prevention feature" The technical differences between this part and ISO 7886-4:2006, as well as the reasons, are as follows:

- Regarding normative references, this part has made adjustments with technical differences, to adapt to China's technical conditions. The adjustments are specifically reflected in Chapter 2 "Normative references"; the specific adjustments are as follows:

- DELETE the ISO 7000;

- DELETE the ASTM D999-01;

- DELETE the ASTM D5276-98;

- USE the GB/T 6682-2008, which modifies and adopts the international standard, to replace ISO 3696:1987;

- USE the GB 15811-2016, which non-equivalently adopts the international standard, to replace ISO 7864:1993 (see 5.6.2);

- USE the GB/T 18457-2015, which modifies and adopts the international standard, to replace ISO 9626 (see 5.6.2);

- USE the GB/T 191-2008, which modifies and adopts the international standard, to replace ISO 780 (see 9.1);

- USE the GB 15810, which modifies and adopts the international standard, to replace ISO 7886-1:1993 (see Chapter 3);

- USE the YY/T 0497, which modifies and adopts the international standard, to replace ISO 8537:1991 (see Chapter 3);

1 Scope

This part of YY/T 0573 specifies the terms and definitions, naming and classification, physical requirements, chemical requirements, biological requirements, packaging, markings, etc. of sterile hypodermic syringes for single use (hereinafter referred to as syringes) with re-use prevention features.

This part applies to sterile hypodermic syringes for single use, which are made of plastic materials, with or without needles, used for aspirating liquids OR for injection immediately after aspirating liquids, designed to prevent re-use. It is suitable for the re-use prevention performance of syringe, which can prevent accidental needle stick injury. This part does not involve the performance of preventing accidental needle stick injury of this type of syringe.

This part does not apply to glass syringes, self-destructive fixed-dose vaccine syringes, syringes with prefilled liquid medicine. This part does not involve the compatibility of the syringe and the injection liquid.

This part does not specify the design requirements for self-destructive features.

Note: When the syringe is used beyond the intended use, which is specified in this part, other standards apply.

2 Normative references

The following documents are essential to the application of this document. For the dated documents, only the versions with the dates indicated are applicable to this document; for the undated documents, only the latest version (including all the amendments) is applicable to this standard.

GB/T 191-2008 Packaging - Pictorial marking for handling of goods (ISO 780:1997, MOD)

GB/T 1962.1 Conical fittings with a 6% (Luer) taper for syringes, needles and certain other medical equipment - Part 1: General requirement (GB/T 1962.1-2015, ISO 594-1:1986, IDT)

GB/T 1962.2 Conical fittings with a 6% (Luer) taper for syringes, needles and certain other medical equipment - Part 2: Lock fittings (GB/T 1962.2-2001, the needle seat.

When tested according to Appendix C, there shall be no gas leakage, at the piston or sealing ring; meanwhile the reading of the pressure gauge shall not continue to drop.

5 Physical requirements

5.7.3 Re-use prevention features

In normal use OR when tested according to Appendix E, in accordance with the manufacturer's instructions for use, once the re-use prevention feature is activated, the syringe shall not be used again.

6 Chemical requirements

6.1 pH

When measuring with a potentiometric pH meter and the corresponding universal electrode, the difference, BETWEEN the pH of the extract, which is prepared according to F.1 of Appendix F AND the pH of the blank solution, shall be <= 1.

6.2 Extractable metal content

Take the extract, which is prepared in F.1. Use a confirmed microanalysis method (such as atomic absorption method OR inductively coupled plasma emission spectrometry) to carry out the test. The total content of lead, tin, zinc, iron in the syringe extract shall be <= 5 µg/mL; the cadmium content shall be <= 0.1 µg/mL.

6.3 Easily oxidized substance

Take the 20 mL of extract, which is prepared in F.1. Test it according to the second method in 5.2.2 of GB/T 14233.1-2008. When compared the syringe extract with the same volume of the same batch of blank control solution, The difference in the consumption of 0.002 mol/L potassium permanganate solution shall be <= 0.5 mL.

6.4 Residual ethylene oxide

If ethylene oxide is used for sterilization, the control of residual ethylene oxide shall be confirmed. When tested according to F.2, the residual amount of ethylene oxide shall be <= 10 µg/g.

7 Biological requirements

7.1 General

It should refer to the guidelines, which are given in Appendix G, to select the appropriate material of syringe. Meanwhile it shall conduct biocompatibility evaluation.

7.2 Sterility

The syringe, in each initial package, shall be sterilized by an appropriate method. The sterilization process shall be confirmed and routinely controlled, to ensure that the survival probability of bacteria on the product is less than 10-6. The confirmation of the sterilization process shall be documented.

Note: GB/T 14233.2 stipulates the sterility test method; this method is suitable for type inspection BUT not for exit-factory inspection. For suitable sterilization and exit-factory sterility inspection methods, see GB 18278.1, GB 18279.1 or GB 18280.1.

7.3 Bacterial endotoxin

When tested according to the method specified in GB/T 14233.2, the bacterial endotoxin limit shall not exceed 20 EU per tube.

8 Packaging

8.1 Initial packaging or self-sealing packaging

The self-sealing syringe unit, which has needle cap and end cap, shall adopt the self-sealing packaging. The syringe unit, without needle cap and end cap, shall be packed in a single package.

When using ethylene oxide for sterilization, the initial packaging of non-self-sealing syringes shall be made of air-permeable materials (such as dialysis paper) on at least one side.

This part encourages the use of packaging materials with better ventilation effects. Packaging materials must not have a harmful effect on the contents. This packaging material and design shall ensure:

a) Under dry, clean and fully ventilated storage conditions, it shall ensure that the contents are sterile;

b) When taken out of the package, the risk of contamination of the contents is minimal;

c) During normal handling, transportation, storage, the contents are adequately protected;

d) Once opened, the package cannot be easily resealed, meanwhile there shall be obvious signs of tearing. […]

......
This preview omits tables, figures, formulas and parts of the technical clauses. The complete document — 37 pages — is available in the English PDF.

Referenced standards

Similar standards

Editions of YY/T 0573.4

EditionTitleRevisionStatus
YY/T 0573.4-2020Sterile hypodermic syringes for single use - Part 4: Syringes with re-use prevention featurecurrent editionCurrent
YY 0573.4-2010Sterile hypodermic syringes for single use - Part 4: Syringes with re-use prevention featureprevious editionSuperseded

This page sells the current edition, YY/T 0573.4-2020. Earlier editions are listed for reference only.

How to Download YY/T 0573.4-2020

  1. 1

    Add to cart

    Click "Download PDF" on this page and choose "Buy this standard". You can add more standards before checkout.

  2. 2

    Checkout

    Enter your email and billing details. Payment is processed securely by Stripe (cards or bank transfer). Prefer bank details? Request a quotation (min. order $300).

  3. 3

    Instant delivery (0–9 sec)

    Delivery is automatic: within seconds of payment you'll receive an email with a secure download link. The link stays valid for 72 hours.

  4. 4

    Invoice included

    A tax invoice is attached to the confirmation email. Need a custom invoice? Contact us.

Related Standards

English PDF
37 pages
Instant delivery (0–9 sec)
Invoice included
View Cart

Secure payment via Stripe

Payments accepted

VisaMastercardAmerican ExpressApple PayGoogle PayStripe

YY/T 0573.4-2020

$385.00